Home Tags Lung Disease

Lung Disease Related Content

Tobacco dependency: Treat it like any other illness

Sarah MacFadyen, Vice Chair of the Taskforce for Lung Health and Head of Policy and External Affairs at Asthma UK and the British Lung Foundation, says it’s time that tobacco dependency was treated just like any other illness.
respiratory symptoms

Smoking both e-cigs & tobacco cigarettes increases risk of respiratory symptoms

Research led by investigators at Massachusetts General Hospital reveals that people who use both e-cigarettes and tobacco cigarettes are more likely to develop respiratory symptoms compared to those using either one alone.
lung conditions

How has COVID-19 affected people with lung conditions?

The impact of COVID-19 has proven that we cannot let people with lung conditions continue to be forgotten, says Dr Alison Cook, Chair of the Taskforce for Lung Health.
COVID in elderly patients, lung

Existing drugs could be used to fight COVID-19 in elderly patients

A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.
lung cancer diagnosis

Earlier lung cancer diagnosis research receives £3.5 million from UKRI

UK Research and Innovation (UKRI) has awarded £3.5 million-worth of funding to help ground-breaking medical research find new ways to diagnose lung cancer earlier.
inflammatory, COVID-19 complication

Removal of inflammatory ‘evil humors’ – the key to treating COVID-19 complications?

Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.
soot

Bonfire Night pollutes our air with large amounts of soot

Researchers from the University of Leeds have discovered that soot in the atmosphere around Bonfire Night is 100 times its normal level.
treatments for heart failure,

Innovative treatments for heart failure

Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
pulmonary fibrosis, Ehealth

Using eHealth applications to improve care for patients with pulmonary fibrosis

Karen Moor and Marlies Wijsenbeek discuss how pulmonary fibrosis patients can be helped by the new possibilities of eHealth apps.
chronic inflammatory lung diseases

Soluble circulating cytokine receptors in chronic inflammatory lung diseases

Michael Roth discusses soluble circulating cytokine receptors in chronic inflammatory lung diseases, which he describes as the under-estimated regulators of inflammation and remodelling.
idiopathic pulmonary fibrosis

Lung disease: A focus on idiopathic pulmonary fibrosis

Stephen C Clark, from Newcastle upon Tyne Hospitals NHS Foundation Trust and University of Northumbria in the UK explains idiopathic pulmonary fibrosis, a type of lung disease.
inflammatory lung diseases

Fine dust air pollution (PM2.5) as a cause of chronic inflammatory lung diseases?

Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.
air pollution in the UK

How has air pollution in the UK improved over recent years?

Daikin reviews whether air pollution in the UK has improved over the years and details how chemical compounds and matter existing in our air pose a threat to our planet.
Living with Chronic Obstructive Pulmonary Diseases

Living with Chronic Obstructive Pulmonary Diseases (COPD)

More can be done at the local, national and EU level to improve COPD diagnosis, support smoking cessation and advance work and living conditions for people living with COPD.
cystic fibrosis drugs, NHS england, vertex pharmaceuticals

Cystic fibrosis drugs agreement secured by NHS England

NHS England has announced it has secured a definitive cystic fibrosis drugs agreement with Vertex Pharmaceuticals, to use all three of their UK-licensed medicines.
incurable lung disease,idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis: An incurable lung disease

Steve Jones, Chair Action for Pulmonary Fibrosis and Board Member EU-IPFF and Gisli Jenkins from Nottingham University Hospitals, explain idiopathic pulmonary fibrosis (IPF), an incurable lung disease.
idiopathic pulmonary fibrosis

The role of eHealth tools in idiopathic pulmonary fibrosis care and research

Karen Moor and Marlies Wijsenbeek from the Erasmus Medical Center, Rotterdam explore the role of eHealth tools in idiopathic pulmonary fibrosis care and research.
cell-cell interaction, astma

Does disturbed cell-cell interaction cause asthma?

Michael Roth, Research Group Leader at University Hospital Basel asks if disturbed cell-cell interaction causes asthma and provides a fascinating response.
respiratory disease

Research reveals sugar could cure respiratory diseases

The restriction or inhalation of common sugar could one day treat a range of respiratory diseases, according to new research led by University of Manchester biologists.
common lung conditions, heart disease

Research links common lung conditions to heart disease

The University of Manchester found that patients with common lung diseases are substantially more likely to suffer a heart attack and develop other major heart problems.

Follow Open Access Government